145 related articles for article (PubMed ID: 23325550)
1. Identification of DNA-dependent protein kinase catalytic subunit as a novel interaction partner of lymphocyte enhancer factor 1.
Shimomura A; Takasaki A; Nomura R; Hayashi N; Senda T
Med Mol Morphol; 2013 Mar; 46(1):14-9. PubMed ID: 23325550
[TBL] [Abstract][Full Text] [Related]
2. Lymphoid enhancer factor-1 mediates loading of Pax3 to a promoter harbouring lymphoid enhancer factor-1 binding sites resulting in enhancement of transcription.
Christova T; Mojtahedi G; Hamel PA
Int J Biochem Cell Biol; 2010 May; 42(5):630-40. PubMed ID: 20006729
[TBL] [Abstract][Full Text] [Related]
3. LEF1 Enhances the Progression of Colonic Adenocarcinoma via Remodeling the Cell Motility Associated Structures.
Xiao L; Zhang C; Li X; Jia C; Chen L; Yuan Y; Gao Q; Lu Z; Feng Y; Zhao R; Zhao X; Cheng S; Shu Z; Xu J; Duan W; Nie G; Hou Y
Int J Mol Sci; 2021 Oct; 22(19):. PubMed ID: 34639214
[TBL] [Abstract][Full Text] [Related]
4. Induction of LEF1 by MYC activates the WNT pathway and maintains cell proliferation.
Hao YH; Lafita-Navarro MC; Zacharias L; Borenstein-Auerbach N; Kim M; Barnes S; Kim J; Shay J; DeBerardinis RJ; Conacci-Sorrell M
Cell Commun Signal; 2019 Oct; 17(1):129. PubMed ID: 31623618
[TBL] [Abstract][Full Text] [Related]
5. Knockdown of lymphoid enhancer factor 1 inhibits colon cancer progression in vitro and in vivo.
Wang WJ; Yao Y; Jiang LL; Hu TH; Ma JQ; Liao ZJ; Yao JT; Li DF; Wang SH; Nan KJ
PLoS One; 2013; 8(10):e76596. PubMed ID: 24098538
[TBL] [Abstract][Full Text] [Related]
6. Interaction of LEF1 with TAZ is necessary for the osteoblastogenic activity of Wnt3a.
Kida J; Hata K; Nakamura E; Yagi H; Takahata Y; Murakami T; Maeda Y; Nishimura R
Sci Rep; 2018 Jul; 8(1):10375. PubMed ID: 29991769
[TBL] [Abstract][Full Text] [Related]
7. Diverse LEF/TCF Expression in Human Colorectal Cancer Correlates with Altered Wnt-Regulated Transcriptome in a Meta-Analysis of Patient Biopsies.
Mayer CD; Giclais SM; Alsehly F; Hoppler S
Genes (Basel); 2020 May; 11(5):. PubMed ID: 32403323
[TBL] [Abstract][Full Text] [Related]
8. The transcription factor Lef1 switches partners from β-catenin to Smad3 during muscle stem cell quiescence.
Aloysius A; DasGupta R; Dhawan J
Sci Signal; 2018 Jul; 11(540):. PubMed ID: 30042129
[TBL] [Abstract][Full Text] [Related]
9. A WNT/p21 circuit directed by the C-clamp, a sequence-specific DNA binding domain in TCFs.
Hoverter NP; Ting JH; Sundaresh S; Baldi P; Waterman ML
Mol Cell Biol; 2012 Sep; 32(18):3648-62. PubMed ID: 22778133
[TBL] [Abstract][Full Text] [Related]
10. Ligand-independent canonical Wnt activity in canine mammary tumor cell lines associated with aberrant LEF1 expression.
Gracanin A; Timmermans-Sprang EP; van Wolferen ME; Rao NA; Grizelj J; Vince S; Hellmen E; Mol JA
PLoS One; 2014; 9(6):e98698. PubMed ID: 24887235
[TBL] [Abstract][Full Text] [Related]
11. A unique DNA binding domain converts T-cell factors into strong Wnt effectors.
Atcha FA; Syed A; Wu B; Hoverter NP; Yokoyama NN; Ting JH; Munguia JE; Mangalam HJ; Marsh JL; Waterman ML
Mol Cell Biol; 2007 Dec; 27(23):8352-63. PubMed ID: 17893322
[TBL] [Abstract][Full Text] [Related]
12. CircMYO10 promotes osteosarcoma progression by regulating miR-370-3p/RUVBL1 axis to enhance the transcriptional activity of β-catenin/LEF1 complex via effects on chromatin remodeling.
Chen J; Liu G; Wu Y; Ma J; Wu H; Xie Z; Chen S; Yang Y; Wang S; Shen P; Fang Y; Fan S; Shen S; Fang X
Mol Cancer; 2019 Oct; 18(1):150. PubMed ID: 31665067
[TBL] [Abstract][Full Text] [Related]
13. Differential expression of LEF1/TCFs family members in colonic carcinogenesis.
Han W; He L; Cao B; Zhao X; Zhang K; Li Y; Beck P; Zhou Z; Tian Y; Cheng S; Wang H
Mol Carcinog; 2017 Nov; 56(11):2372-2381. PubMed ID: 27433921
[TBL] [Abstract][Full Text] [Related]
14. Domain-specific regulation of foxP2 CNS expression by lef1.
Bonkowsky JL; Wang X; Fujimoto E; Lee JE; Chien CB; Dorsky RI
BMC Dev Biol; 2008 Oct; 8():103. PubMed ID: 18950487
[TBL] [Abstract][Full Text] [Related]
15. Association of Smads with lymphoid enhancer binding factor 1/T cell-specific factor mediates cooperative signaling by the transforming growth factor-beta and wnt pathways.
Labbé E; Letamendia A; Attisano L
Proc Natl Acad Sci U S A; 2000 Jul; 97(15):8358-63. PubMed ID: 10890911
[TBL] [Abstract][Full Text] [Related]
16. SNAIL1 employs β-Catenin-LEF1 complexes to control colorectal cancer cell invasion and proliferation.
Freihen V; Rönsch K; Mastroianni J; Frey P; Rose K; Boerries M; Zeiser R; Busch H; Hecht A
Int J Cancer; 2020 Apr; 146(8):2229-2242. PubMed ID: 31463973
[TBL] [Abstract][Full Text] [Related]
17. WNT/TCF signaling through LEF1 and HOXB9 mediates lung adenocarcinoma metastasis.
Nguyen DX; Chiang AC; Zhang XH; Kim JY; Kris MG; Ladanyi M; Gerald WL; Massagué J
Cell; 2009 Jul; 138(1):51-62. PubMed ID: 19576624
[TBL] [Abstract][Full Text] [Related]
18. Xom interacts with and stimulates transcriptional activity of LEF1/TCFs: implications for ventral cell fate determination during vertebrate embryogenesis.
Gao H; Wu B; Giese R; Zhu Z
Cell Res; 2007 Apr; 17(4):345-56. PubMed ID: 17404593
[TBL] [Abstract][Full Text] [Related]
19. Groucho binds two conserved regions of LEF-1 for HDAC-dependent repression.
Arce L; Pate KT; Waterman ML
BMC Cancer; 2009 May; 9():159. PubMed ID: 19460168
[TBL] [Abstract][Full Text] [Related]
20. Wnt pathway component LEF1 mediates tumor cell invasion and is expressed in human and murine breast cancers lacking ErbB2 (her-2/neu) overexpression.
Nguyen A; Rosner A; Milovanovic T; Hope C; Planutis K; Saha B; Chaiwun B; Lin F; Imam SA; Marsh JL; Holcombe RF
Int J Oncol; 2005 Oct; 27(4):949-56. PubMed ID: 16142310
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
